Author

J. L. Usachenko

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:non-human primate· 1 Organism:rat· 1 Research Focus:spatial domain detection· 1

Frequent Co-Authors

J. K. Watanabe· 2 shared K. K. A. Van Rompay· 2 shared R. Immareddy· 2 shared A. A. Ardeshir· 1 shared A. Fowler· 1 shared A. Jain· 1 shared A. M. Allen· 1 shared A. T. Remaley· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. K. Watanabe

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A Virus-like particle-based bivalent PCSK9 vaccine lowers LDL-cholesterol levels in Non-Human Primates

A. Fowler, K. K. A. Van Rompay, M. Sampson, J. Leo, J. K. Watanabe, J. L. Usachenko, R. Immareddy, D. M. Lovato, J. T. Schiller, A. T. Remaley, B. Chackerian

A bivalent PCSK9 vaccine using virus-like particles reduces LDL-cholesterol in non-human primates without statins, showing vaccine efficacy in cholesterol management.

bioRxiv · May 15, 2023Immunology

Early post-infection treatment of SARS-CoV-2 infected macaques with human convalescent plasma with high neutralizing activity reduces lung inflammation

K. K. A. Van Rompay, K. J. Olstad, R. L. Sammak, J. Dutra, J. K. Watanabe, J. L. Usachenko, R. Immareddy, J. W. Roh, A. Verma, Y. Shaan Lakshmanappa, B. Schmidt, C. Di Germanio, N. Rizvi, M. Stone, G. Simmons, , J. R. Reader

This study treats SARS-CoV-2 infected macaques with high-titer convalescent plasma, showing reduced lung inflammation without affecting virus replication.

bioRxiv · Sep 1, 2021 · PreprintImmunology